US health authorities have lifted restrictions on the use of the anti-diabetes drug Avandia after a study finding that it did not carry a higher risk of heart attacks. The US Food and Drug Administration (FDA) announced the decision after considering the recommendations made by a 26-member panel of experts on June 6. "Our actions today reflect the most current scientific knowledge about the risks and benefits of this drug," said Janet Woodcock, ...
Read More
No comments:
Post a Comment